High prevalence of germline TP53 mutations in young osteosarcoma cases

被引：2

作者：

Mirabello, Lisa J. ^{[1
]}

Yeager, Meredith ^{[2
]}

Mai, Phuong L. ^{[1
]}

Gastier-Foster, Julie ^{[3
,4
]}

Gorlick, Richard ^{[5
]}

Khanna, Chand ^{[6
]}

Patino-Garcia, Ana ^{[7
]}

Sierrasesumaga, Luis ^{[7
]}

Lecanda, Fernando ^{[7
]}

Andrulis, Irene L. ^{[8
]}

Wunder, Jay S. ^{[8
]}

Gokgoz, Nalan ^{[8
]}

Barkauskas, Donald A. ^{[9
]}

Zhang, Xijun ^{[2
]}

Vogt, Aurelie ^{[2
]}

Jones, Kristine ^{[2
]}

Boland, Joseph F. ^{[2
]}

Chanock, Stephen J. ^{[1
]}

Savage, Sharon A. ^{[1
]}

机构：

[1] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA

[2] Leidos Biomed Res, Frederick Natl Lab Canc Res, Frederick, MD USA

[3] Nationwide Childrens Hosp, Columbus, OH USA

[4] Ohio State Univ, Dept Pathol & Pediat, Columbus, OH 43210 USA

[5] Childrens Hosp, Albert Einstein Coll Med, Montefiore, NY USA

[6] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

[7] Univ Navarra, Univ Navarra Clin, Dept Pediat, E-31080 Pamplona, Spain

[8] Univ Toronto, Litwin Ctr Canc Genet, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hosp, Toronto, ON M5S 1A1, Canada

[9] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA

来源：

CANCER RESEARCH | 2015年 / 75卷

关键词：

D O I：

10.1158/1538-7445.AM2015-5574

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5574

引用

页数：3

共 50 条

[21] Clinical implications of germline mutations in breast cancer: TP53
Schon, Katherine
Tischkowitz, Marc
BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 417 - 423
[22] Loss of heterozygosity in tumours of carriers of germline TP53 mutations
Goetz, P
Trkova, M
Foretova, L
Krutilkova, V
Kodet, R
Mares, J
Sedlacek, Z
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 89 - 89
[23] Molecular characteristics of novel germline mutations in TP53 in Sweden
Kharaziha, P.
Larsson, C.
Tham, E.
Bajalica-Lagercrantz, S.
EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 606 - 607
[24] TP53 mutations and outcome in osteosarcoma:: A prospective, multicenter study
Wunder, JS
Gokgoz, N
Parkes, R
Bull, SB
Eskandarian, S
Davis, AM
Beauchamp, CP
Conrad, EU
Grimer, RJ
Healey, JH
Malkin, D
Mangham, DC
Rock, MJ
Bell, RS
Andrulis, IL
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1483 - 1490
[25] Contribution of germline TP53 mutation in sporadic sarcoma cases
Haque, Md. M.
Puri, A.
Sarin, R.
EUROPEAN JOURNAL OF CANCER, 2016, 54 : S52 - S52
[26] Low prevalence of TP53 mutations in pediatric rhabdomyosarcoma
Ognjanovic, Simona
Martel-Planche, Ghyslaine
Olivier, Magali
Hainaut, Pierre
CANCER RESEARCH, 2010, 70
[27] The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations
Finkova, Alena
Vazna, Alzbeta
Hrachovina, Ondrej
Bendova, Sarka
Prochazkova, Kamila
Sedlacek, Zdenek
CANCER GENETICS AND CYTOGENETICS, 2009, 193 (01) : 63 - 66
[28] Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients
Rashid, Muhammad U.
Gull, Sidra
Asghar, Kashif
Muhammad, Noor
Amin, Asim
Hamann, Ute
FAMILIAL CANCER, 2012, 11 (02) : 307 - 311
[29] Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients
Muhammad U. Rashid
Sidra Gull
Kashif Asghar
Noor Muhammad
Asim Amin
Ute Hamann
Familial Cancer, 2012, 11 : 307 - 311
[30] Choroid Plexus Carcinomas With TP53 Germline Mutations: Management and Outcome
Li, Yanong
Liu, Hailong
Li, Tandy
Feng, Jin
He, Yanjiao
Chen, Li
Li, Chunde
Qiu, Xiaoguang
FRONTIERS IN ONCOLOGY, 2021, 11

← 1 2 3 4 5 →